IN SITU HYBRIDIZATION, WITH OR WITHOUT TYRAMIDE SIGNAL AMPLIFICATION, IN EVALUATION OF HUMAN PAPILLOMAVIRUS STATUS INEARLY STAGE CERVICAL CARCINOMA
Kubelka-Sabit KB*, Prodanova ILj, Zografski GD, Basheska NT
*Corresponding Author: Katerina Kubelka-Sabit, M.D., M.Sci., Department of Histopathology and Clinical Cytology, Institute of Radiotherapy and Oncology, Medical Faculty, Vodnjanska 17, 1000 Skopje, Republic of Macedonia; Tel.: +389-2-3147-902; Fax: +389-2-3111-430 ; E-mail:catkubelka@yahoo.co.uk
page: 41

Abstract

 

Conventional in situ hybridization (CISH) can be used for detection of human papillomavirus (HPV) DNA, enabling preservation of the tissue morphology and assessment of the physical state of viral DNA, but has low sensitivity. This study compared the sensitivity and efficiency of in situ hybridization with tyramide signal amplification (ISH TSA) with those of CISH. The HPV status of 77 cases with early stage cervical carcinoma was evaluated with CISH, using biotinylated probes for HPV types 6/11, 16/18 and 31/33/51, and with ISH TSA using probes for HPV types 6/11, 16/18 and 31/33 or 31/33/51. The HPV DNA was detected in 26 (33.8%) cases using CISH, and in 45 (58.4%) cases using ISH TSA. By adding the TSA step, the sensitivity of CISH was enhanced by 24.7%, thus enabling detection of 20 new HPV-positive cases. Multiple HPV infections were detected in four cases. A dot signal pattern was present in 68.9% (31/45) and more than five positive nuclei per sample were found in 82.2% (37/45) of the cases. We found that the ISH TSA system is a fast and simple method for detection of HPV DNA in cervical carcinoma compared to CISH, and is more sensitive and efficient in the detection and typing of HPV, assessment of HPV DNA physical state and evaluation of the number of positive cells than CISH. Key words: Cervical carcinoma; Human papilloma virus (HPV); In situ hybridization (ISH); Tyramide signal amplification (TSA).




Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006